Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Surg. Dec 27, 2012; 4(12): 284-288
Published online Dec 27, 2012. doi: 10.4240/wjgs.v4.i12.284
Published online Dec 27, 2012. doi: 10.4240/wjgs.v4.i12.284
Does perioperative prostaglandin E1 affect survival of patients with esophageal cancer?
Fahimeh Farrokhnia, Department of Anesthesiology, the Cancer Institute, Imam Khomeini Medical Center, Tehran University of Medical Sciences, Tehran 15614, Iran
Jalil Makarem, Department of Anesthesiology and Intensive Care, Imam Khomeini Medical Center, Tehran University of Medical Sciences, Tehran 15614, Iran
Habibollah Mahmoodzadeh, Department of Surgery, the Cancer Institute, Imam Khomeini Medical Center, Tehran University of Medical Sciences, Tehran 15614, Iran
Nazanin Andalib, School of Biology, Campus of Science, University of Tehran, Tehran, Iran
Author contributions: Farrokhnia F, Makarem J, Mahmoodzadeh H and Andalib N contributed equally to the paper.
Supported by The Cancer Research Center of the Cancer Institute in Iran
Correspondence to: Fahimeh Farrokhnia, MD, Department of Anesthesiology and Intensive Care, Imam Khomeini Medical Center, Keshavarz Blvd, Tehran 15614, Iran. farrokhnia1503@yahoo.com
Telephone: +98-21-66438634 Fax: +98-21-66438634
Received: August 20, 2011
Revised: October 17, 2012
Accepted: December 20, 2012
Published online: December 27, 2012
Revised: October 17, 2012
Accepted: December 20, 2012
Published online: December 27, 2012
Core Tip